Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D003374:Coumarins / Q000097:blood / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004357:Drug Synergism; D005017:Ethyl Biscoumacetate / Q000494:pharmacology; D066298:In Vitro Techniques; D007279:Injections, Subcutaneous; D010653:Phenylbutazone / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects; D011517:Prothrombin Time; D011720:Pyrazoles / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D014859:Warfarin / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D003374:Coumarins; D011720:Pyrazoles; D005017:Ethyl Biscoumacetate; D014859:Warfarin; D000244:Adenosine Diphosphate; D010653:Phenylbutazone